JPMorgan Chase JPM has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 11 | 4 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 7 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 3 | 2 | 0 | 0 |
Analysts have set 12-month price targets for JPMorgan Chase, revealing an average target of $217.0, a high estimate of $239.00, and a low estimate of $185.00. This upward trend is apparent, with the current average reflecting a 2.33% increase from the previous average price target of $212.06.
Exploring Analyst Ratings: An In-Depth Overview
The standing of JPMorgan Chase among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Betsy Graseck | Morgan Stanley | Raises | Overweight | $226.00 | $221.00 |
| Glenn Schorr | Evercore ISI Group | Raises | Outperform | $211.00 | $210.00 |
| Keith Horowitz | Citigroup | Raises | Neutral | $215.00 | $205.00 |
| Mike Mayo | Wells Fargo | Raises | Overweight | $225.00 | $220.00 |
| Scott Siefers | Piper Sandler | Raises | Overweight | $230.00 | $220.00 |
| Jason Goldberg | Barclays | Raises | Overweight | $217.00 | $212.00 |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $221.00 | $215.00 |
| Betsy Graseck | Morgan Stanley | Raises | Overweight | $221.00 | $214.00 |
| David Konrad | Keefe, Bruyette & Woods | Raises | Market Perform | $211.00 | $209.00 |
| Ken Usdin | Jefferies | Raises | Buy | $239.00 | $230.00 |
| Glenn Schorr | Evercore ISI Group | Maintains | Outperform | $210.00 | $210.00 |
| Gerard Cassidy | RBC Capital | Maintains | Outperform | $211.00 | $211.00 |
| Erika Najarian | UBS | Raises | Buy | $224.00 | $219.00 |
| Betsy Graseck | Morgan Stanley | Lowers | Overweight | $214.00 | $216.00 |
| Scott Siefers | Piper Sandler | Raises | Overweight | $220.00 | $215.00 |
| David George | Baird | Raises | Neutral | $185.00 | $175.00 |
| David Konrad | Keefe, Bruyette & Woods | Raises | Market Perform | $209.00 | $203.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to JPMorgan Chase. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of JPMorgan Chase compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for JPMorgan Chase's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into JPMorgan Chase's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on JPMorgan Chase analyst ratings.
About JPMorgan Chase
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $3.9 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
Financial Milestones: JPMorgan Chase's Journey
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: JPMorgan Chase's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 0.94%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: JPMorgan Chase's net margin is impressive, surpassing industry averages. With a net margin of 41.89%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): JPMorgan Chase's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.68%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): JPMorgan Chase's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.43% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 2.04, JPMorgan Chase faces challenges in effectively managing its debt levels, indicating potential financial strain.
What Are Analyst Ratings?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
